Perpetual Ltd’s Procept Biorobotics PRCT Stock Holding History

Perpetual Ltd’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-831,739	Closed	-$67M	–	430
2024 Q4	$67M	Buy	+831,739	New	+$71.1M	0.79%	48

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perpetual Ltd's PRCT Position: Q1 2025 in Review

Perpetual Ltd sold out of Procept Biorobotics (PRCT) in Q1 2025, closing a stake of 831,739 shares — an estimated $67M sold.

Perpetual Ltd first reported a position in PRCT in Q4 2024 and held it in 1 quarter. The position peaked at $67M in Q4 2024. 279 funds tracked by Wall St. Rank hold PRCT as of Q1 2025.

Perpetual Ltd reported no remaining Procept Biorobotics position as of Q1 2025 after selling out during the quarter.
Perpetual Ltd sold 831,739 Procept Biorobotics shares in Q1 2025, an estimated $67M.
Perpetual Ltd first reported a position in Procept Biorobotics in Q4 2024 and held it in 1 quarter.
Perpetual Ltd's Procept Biorobotics position peaked at $67M in Q4 2024.
279 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2025.

Based on Perpetual Ltd's 13F filing for Q1 2025, filed 24 Apr 2025.